Loading provider…
Loading provider…
Ophthalmology Physician in Baltimore, MD
NPI: 1225063035Primary Practice Location
JOHNS HOPKINS HOSPITAL, THE
1800 Orleans St, Baltimore, MD
Primary Employer
Jhu - Wilmer Eye Institute
hopkinsmedicine.org
HQ Phone
Get M.D. Jennifer's Phone Numberphone_androidMobile
Get M.D. Jennifer's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 141 | 285 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 61 | 66 |
| 3 | 92134Diagnostic imaging of retina | 60 | 83 |
| 4 | 92083Measurement of field of vision during daylight conditions | 42 | 46 |
| 5 | 92250Photography of the retina | 42 | 62 |
Characterizing the Human Immunodeficiency Virus Care Continuum Among Transgender Women and Cisgender Women and Men in Clinical Care: A Retrospective Time-series Analysis.
Authors: Michael Silverberg, Karla Perez-Goldberg, William Mathews, Michael Horberg, Mari Kitahata, Joseph Eron
Publication Date: 2019-01-22
Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america.
Authors: Timothy Sterling, Kelly Gebo, Michael Horberg
Publication Date: 2011-08-05
Lead Sponsor: JHSPH Center for Clinical Trials
Collaborators: National Eye Institute (NEI)
Intervention / Treatment: DRUG: Dexamethasone intravitreal implant 0.7 mg, DRUG: Intravitreal Methotrexate 400 µg, DRUG: Intravitreal Ranibizumab 0.5 mg
Lead Sponsor: Nisha Acharya
Collaborators: Children's Hospital of Philadelphia, National Eye Institute (NEI), University of Miami, University of Utah, Children's Hospital Medical Center, Cincinnati, University of California, Davis, Vanderbilt University Medical Center, Children's Mercy Hospital Kansas City, Royal Children's Hospital, Norfolk and Norwich University Hospitals NHS Foundation Trust, Manchester University NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, University of Texas at Austin, Great Ormond Street Hospital for Children NHS Foundation Trust, University Hospitals Bristol and Weston NHS Foundation Trust, Alder Hey Children's NHS Foundation Trust, Newcastle-upon-Tyne Hospitals NHS Trust, Sheffield Children's NHS Foundation Trust, University Hospitals, Leicester, Colorado Retina Associates
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Adalimumab
Lead Sponsor: JHSPH Center for Clinical Trials
Collaborators: National Eye Institute (NEI)
Intervention / Treatment: DRUG: Periocular triamcinolone 40 mg, DRUG: Intravitreal triamcinolone 4 mg, DRUG: Dexamethasone intravitreal implant